Norris Medicines Limited (BSE: 524414)
Health Care · Pharmaceuticals · IN
Rs15.25
-6.44% today · -3.7% 1Y
Norris Medicines Limited (BSE: 524414) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.58M.
Over the last twelve months the share price has lost 3.7%, trading between 12.00 and 20.06.
Tweenvest scores Norris Medicines Limited across four factors: quality 37/100, value 39/100, growth 0/100. Its strongest factor is value.
524414 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.58M
- Revenue (TTM)
- $803.84K
- P/E
- —
- EPS
- -0.37
- Dividend yield
- —
- Beta (5Y)
- -0.48
- 52-week high
- Rs20.06
- 52-week low
- Rs12.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zenith Healthcare LimitedBSE: 530665 | $1.72M | Rs3.10 | -1.59% |
| Captor Capital Corp.CNSX: CPTR | $1.64M | CA$0.67 | +15.52% |
| Sunrest Lifescience LimitedNSEI: SUNREST | $1.63M | Rs36.75 | +3.52% |
| Desh Rakshak Aushdhalaya LimitedBSE: 531521 | $1.62M | Rs— | — |
| Shamrock Industrial Company LimitedBSE: 531240 | $1.54M | Rs27.25 | +4.97% |
| CanadaBis Capital Inc.TSXV: CANB | $1.53M | CA$— | — |
| Gabather AB (publ)OM: GABA | $1.47M | Skr0.02 | -16.67% |
| Avenue Therapeutics, Inc.OTCPK: ATXI | $1.42M | $0.43 | +5.45% |
Figures last refreshed Oct 11, 2026.